S. Sturrock

Comparison of Four PD‐L1 Immunohistochemical Assays in Lung Cancer

S. Fox, S. Hendry, W. Cooper, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans.

Mark Shackleton, Gerd Ritter, Simon Green, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial.

A. Scott, M. Brechbiel, K. Inoue, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma.

P. Gibbs, J. Karbach, M. Shackleton, 2003, Cancer immunity.

APhase I Trial of HumanizedMonoclonal AntibodyA 33 in Patients with Colorectal Carcinoma : Biodistribution , Pharmacokinetics , and QuantitativeTumor Uptake

A. Scott, A. Burgess, A. Papenfuss, 2005 .

Molecular analysis in the diagnosis of pediatric lymphomas.

M. Southey, D. Venter, C. Chow, 1996, Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association.

Immunohistochemical and Molecular Analysis of Human Melanomas for Expression of the Human Cancer-Testis Antigens NY-ESO-1 and LAGE-1

Yao-Tseng Chen, L. Old, I. Davis, 2004, Clinical Cancer Research.

Characterization of antigen-specific CD8+ T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccination.

M. Shackleton, I. Davis, J. Cebon, 2005, Cancer immunity.

Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage

I. Davis, A. Jungbluth, J. Cebon, 2006, Clinical Cancer Research.

A Phase I Trial of Humanized Monoclonal Antibody A33 in Patients with Colorectal Carcinoma: Biodistribution, Pharmacokinetics, and Quantitative Tumor Uptake

Robert Jones, Edouard C. Nice, Lloyd J. Old, 2005, Clinical Cancer Research.

Erratum: Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans (Proceedings of the National Academy of Sciences of the United States of America (July 20, 2004) 101, 29 (10697-10702))

A. Scott, Yao-Tseng Chen, G. McArthur, 2005 .

Improving interpretation of biopsies during microsurgical testicular sperm exploration in azospermic patients: use of Davidson's fluid.

S. Sturrock, S. Appu, L. Galea, 2021, Pathology.